SKP2 and neoplasm: For example, SKP2 is overexpressed in breast, prostate, colorectal, and pancreatic cancers as well as lymphoma, melanoma, and nasopharyngeal carcinoma, and is highly correlated with poor tumor prognosis 22-24.